These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 8706072

  • 1. [The effect of fish oil on metabolic parameters in patients with type 2 diabetes mellitus associated with dyslipidemia].
    Zák A, Zeman M, Tvrzická E, Stolba P.
    Cas Lek Cesk; 1996 May 29; 135(11):354-9. PubMed ID: 8706072
    [Abstract] [Full Text] [Related]

  • 2. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
    Zeman M, Zák A, Vecka M, Tvrzická E, Písaríková A, Stanková B.
    Cas Lek Cesk; 2005 May 29; 144(11):737-41. PubMed ID: 16335699
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the effects of omega-3 polyunsaturated fatty acids and Olbetam (Acipimox) in the treatment of hypertriglyceridemia].
    Zák A, Zeman M, Vítková D.
    Cas Lek Cesk; 1994 Dec 22; 133(24):755-8. PubMed ID: 7834677
    [Abstract] [Full Text] [Related]

  • 4. Fish oil supplementation versus gemfibrozil treatment in hyperlipidemic NIDDM. A randomized crossover study.
    Fasching P, Rohac M, Liener K, Schneider B, Nowotny P, Waldhäusl W.
    Horm Metab Res; 1996 May 22; 28(5):230-6. PubMed ID: 8738112
    [Abstract] [Full Text] [Related]

  • 5. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK, Salminen I, Lyssenko V, Virtanen SM, Groop L, Aro A, Saloranta C, Botnia Research Group.
    Eur J Clin Nutr; 2008 Dec 22; 62(12):1432-9. PubMed ID: 17700648
    [Abstract] [Full Text] [Related]

  • 6. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
    Mostad IL, Bjerve KS, Lydersen S, Grill V.
    Eur J Clin Nutr; 2008 Mar 22; 62(3):419-29. PubMed ID: 17327864
    [Abstract] [Full Text] [Related]

  • 7. Randomized study of the safety and efficacy of fish oil (omega-3 fatty acid) supplementation with dietary and exercise counseling for the treatment of antiretroviral therapy-associated hypertriglyceridemia.
    Wohl DA, Tien HC, Busby M, Cunningham C, Macintosh B, Napravnik S, Danan E, Donovan K, Hossenipour M, Simpson RJ.
    Clin Infect Dis; 2005 Nov 15; 41(10):1498-504. PubMed ID: 16231263
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
    Mustad VA, Demichele S, Huang YS, Mika A, Lubbers N, Berthiaume N, Polakowski J, Zinker B.
    Metabolism; 2006 Oct 15; 55(10):1365-74. PubMed ID: 16979408
    [Abstract] [Full Text] [Related]

  • 9. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G, Menéndez R, Más R, Amor A, Fernández JL, González RL, Lezcay M, Alvarez E.
    Int J Clin Pharmacol Res; 2002 Oct 15; 22(3-4):89-99. PubMed ID: 12837046
    [Abstract] [Full Text] [Related]

  • 10. Diacylglycerol oil ingestion in type 2 diabetic patients with hypertriglyceridemia.
    Yamamoto K, Takeshita M, Tokimitsu I, Watanabe H, Mizuno T, Asakawa H, Tokunaga K, Tatsumi T, Okazaki M, Yagi N.
    Nutrition; 2006 Jan 15; 22(1):23-9. PubMed ID: 16289977
    [Abstract] [Full Text] [Related]

  • 11. Effects of low-dose omega-3 fatty acid substitution in type-2 diabetes mellitus with special reference to oxidative stress--a prospective preliminary study.
    Jain S, Gaiha M, Bhattacharjee J, Anuradha S.
    J Assoc Physicians India; 2002 Aug 15; 50():1028-33. PubMed ID: 12421024
    [Abstract] [Full Text] [Related]

  • 12. Consumption of an n-3 polyunsaturated fatty acid-enriched dip modulates plasma lipid profile in subjects with diabetes type II.
    Garg ML, Blake RJ, Clayton E, Munro IA, Macdonald-Wicks L, Singh H, Moughan PJ.
    Eur J Clin Nutr; 2007 Nov 15; 61(11):1312-7. PubMed ID: 17299483
    [Abstract] [Full Text] [Related]

  • 13. The effect of glycemic control in type 2 diabetic patients with diabetes-related dyslipidemia.
    Abdel-Gayoum AG.
    Saudi Med J; 2004 Feb 15; 25(2):207-11. PubMed ID: 14968220
    [Abstract] [Full Text] [Related]

  • 14. Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome.
    Benito P, Caballero J, Moreno J, Gutiérrez-Alcántara C, Muñoz C, Rojo G, Garcia S, Soriguer FC.
    Clin Nutr; 2006 Aug 15; 25(4):581-7. PubMed ID: 16701922
    [Abstract] [Full Text] [Related]

  • 15. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
    Ristić Medić D, Ristić V, Arsić A, Postić M, Ristić G, Blazencić Mladenović V, Tepsić J.
    Nutr Metab Cardiovasc Dis; 2006 Sep 15; 16(6):395-404. PubMed ID: 16935698
    [Abstract] [Full Text] [Related]

  • 16. Effect of soy product kinako and fish oil on serum lipids and glucose metabolism in women with metabolic syndrome.
    Simão AN, Lozovoy MA, Dichi I.
    Nutrition; 2014 Jan 15; 30(1):112-5. PubMed ID: 24290606
    [Abstract] [Full Text] [Related]

  • 17. [Effect of fish oils on plasma lipid risk factors and esterified fatty acids in primary hyperlipoproteinemia].
    Zák A, Zeman M, Tvrzická E.
    Sb Lek; 1997 Jan 15; 98(3):213-24. PubMed ID: 9601814
    [Abstract] [Full Text] [Related]

  • 18. Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients.
    Kasim SE, Stern B, Khilnani S, McLin P, Baciorowski S, Jen KL.
    J Clin Endocrinol Metab; 1988 Jul 15; 67(1):1-5. PubMed ID: 3379125
    [Abstract] [Full Text] [Related]

  • 19. [Diabetic dyslipidemia and pathogenesis of ischemic heart disease].
    Sokolov EI, Perova NV.
    Kardiologiia; 2003 Jul 15; 43(5):16-20. PubMed ID: 12891233
    [Abstract] [Full Text] [Related]

  • 20. Effects of slow release bezafibrate on the lipid pattern and on blood glucose of type 2 diabetic patients with hyperlipidaemia.
    Rovellini A, Sommariva D, Branchi A, Maraffi F, Montalto C, Gandini R, Fasoli A.
    Pharmacol Res; 1992 Apr 15; 25(3):237-45. PubMed ID: 1518767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.